REVELATION BIOSCIENCES, INC. Operating Expenses
REVELATION BIOSCIENCES, INC. (REVB) reported Operating Expenses of $3.66 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- REVELATION BIOSCIENCES, INC. operating expenses for the quarter ending 2026-06-30 was $3.66M, a 48.80% increase year-over-year.
- REVELATION BIOSCIENCES, INC. operating expenses for the quarter ending 2026-03-31 was $3.09M, a 47.61% increase year-over-year.
- REVELATION BIOSCIENCES, INC. operating expenses for the quarter ending 2025-12-31 was $2.57M, a 46.62% increase year-over-year.
- REVELATION BIOSCIENCES, INC. operating expenses for the quarter ending 2025-09-30 was $1.94M, a 8.14% increase year-over-year.
- REVELATION BIOSCIENCES, INC. operating expenses for fiscal 2025 was $9.07M, a 13.74% increase from fiscal 2024.
- REVELATION BIOSCIENCES, INC. operating expenses for fiscal 2024 was $7.98M, a 7.87% decline from fiscal 2023.
- REVELATION BIOSCIENCES, INC. operating expenses for fiscal 2023 was $8.66M, a 20.32% decline from fiscal 2022.
- REVELATION BIOSCIENCES, INC. operating expenses for fiscal 2022 was $10.86M, a 9.09% decline from fiscal 2021.
| Period end | Operating Expenses 1 month | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.66M 10-Q · filed 2026-08-06 | $6.75M 10-Q · filed 2026-08-06 | $9.33M derived: sum of 3 quarters · filed 2026-08-06 | $11.27M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2026-03-31 | $3.09M 10-Q · filed 2026-05-07 | $5.66M derived: sum of 2 quarters · filed 2026-05-07 | $7.61M derived: sum of 3 quarters · filed 2026-05-07 | $10.07M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.51M derived: sum of 2 quarters · filed 2026-02-26 | $6.98M derived: sum of 3 quarters · filed 2026-08-06 | $9.07M 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | $1.94M 10-Q · filed 2025-11-06 | $4.40M derived: sum of 2 quarters · filed 2026-08-06 | $6.50M 10-Q · filed 2025-11-06 | $8.25M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-06-30 | $2.46M 10-Q · filed 2026-08-06 | $4.56M 10-Q · filed 2026-08-06 | $6.31M derived: sum of 3 quarters · filed 2026-08-06 | $8.11M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-03-31 | $2.09M 10-Q · filed 2026-05-07 | $3.85M derived: sum of 2 quarters · filed 2026-05-07 | $5.65M derived: sum of 3 quarters · filed 2026-05-07 | $8.17M derived: sum of 4 quarters · filed 2026-05-07 | |||||
| 2024-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.55M derived: sum of 2 quarters · filed 2026-02-26 | $6.07M derived: sum of 3 quarters · filed 2026-02-26 | $7.98M 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | $1.80M 10-Q · filed 2025-11-06 | $4.32M derived: sum of 2 quarters · filed 2025-11-06 | $6.22M 10-Q · filed 2025-11-06 | $8.55M derived: sum of 4 quarters · filed 2025-11-06 | |||||
| 2024-06-30 | $2.52M 10-Q · filed 2025-08-08 | $4.42M 10-Q · filed 2025-08-08 | $6.75M derived: sum of 3 quarters · filed 2025-08-08 | $9.53M derived: sum of 4 quarters · filed 2025-08-08 | |||||
| 2024-03-31 | $1.90M 10-Q · filed 2025-05-08 | $4.23M derived: sum of 2 quarters · filed 2025-05-08 | $7.01M derived: sum of 3 quarters · filed 2025-05-08 | $8.94M derived: sum of 4 quarters · filed 2025-05-08 | |||||
| 2023-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $5.10M derived: sum of 2 quarters · filed 2025-03-06 | $7.04M derived: sum of 3 quarters · filed 2025-03-06 | $8.66M 10-K · filed 2025-03-06 | |||||
| 2023-09-30 | $2.78M 10-Q · filed 2024-11-08 | $4.71M derived: sum of 2 quarters · filed 2024-11-08 | $6.33M 10-Q · filed 2024-11-08 | $7.55M derived: sum of 4 quarters · filed 2024-11-08 | |||||
| 2023-06-30 | $1.93M 10-Q/A · filed 2024-09-23 | $3.55M 10-Q/A · filed 2024-09-23 | $4.77M derived: sum of 3 quarters · filed 2024-09-23 | $5.97M derived: sum of 4 quarters · filed 2024-09-23 | |||||
| 2023-03-31 | $1.62M 10-Q/A · filed 2024-09-23 | $2.84M derived: sum of 2 quarters · filed 2024-09-23 | $4.04M derived: sum of 3 quarters · filed 2024-09-23 | $5.90M derived: sum of 4 quarters · filed 2024-09-23 | |||||
| 2022-12-31 | $1.22M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-23 | $2.42M derived: sum of 2 quarters · filed 2024-09-23 | $4.28M derived: sum of 3 quarters · filed 2024-09-23 | $10.86M 10-K/A · filed 2024-09-23 | |||||
| 2022-09-30 | $1.20M 10-Q · filed 2023-11-09 | $3.06M derived: sum of 2 quarters · filed 2023-11-09 | $9.65M 10-Q · filed 2023-11-09 | $13.50M derived: sum of 4 quarters · filed 2023-11-09 | |||||
| 2022-06-30 | $1.86M 10-Q · filed 2023-08-11 | $8.45M 10-Q · filed 2023-08-11 | $12.30M derived: sum of 3 quarters · filed 2023-08-11 | $15.35M derived: sum of 4 quarters · filed 2023-08-11 | |||||
| 2022-03-31 | $6.59M 10-Q · filed 2023-05-22 | $10.44M derived: sum of 2 quarters · filed 2023-05-22 | $13.49M derived: sum of 3 quarters · filed 2023-05-22 | $15.93M derived: sum of 4 quarters · filed 2023-05-22 | |||||
| 2021-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $6.90M derived: sum of 2 quarters · filed 2023-03-30 | $9.34M derived: sum of 3 quarters · filed 2023-03-30 | $11.95M 10-K · filed 2023-03-30 | $3.09M 10-K · filed 2022-04-15 | ||||
| 2021-09-30 | $3.04M 10-Q · filed 2022-11-10 | $844.53K 10-Q · filed 2021-10-29 | $5.49M derived: sum of 2 quarters · filed 2022-11-10 | $8.09M 10-Q · filed 2022-11-10 | $2.16M 10-Q · filed 2021-10-29 | $8.23M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $2.44M 10-Q · filed 2022-08-15 | $842.03K 10-Q · filed 2021-08-23 | $5.05M 10-Q · filed 2022-08-15 | $1.31M 10-Q · filed 2021-08-23 | $5.19M derived: sum of 3 quarters · filed 2022-08-15 | $5.19M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $2.61M 10-Q · filed 2022-05-16 | $468.86K 10-Q · filed 2021-06-22 | $2.74M derived: sum of 2 quarters · filed 2022-05-16 | $2.75M derived: sum of 3 quarters · filed 2022-05-16 | $2.75M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $136.94K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $137.81K derived: sum of 2 quarters · filed 2022-04-15 | $138.33K derived: sum of 3 quarters · filed 2022-04-15 | $145.49K 10-K · filed 2022-04-15 | |||||
| 2020-09-30 | $868.00 10-Q · filed 2021-10-29 | $1.39K derived: sum of 2 quarters · filed 2021-10-29 | $8.55K 10-Q · filed 2021-10-29 | ||||||
| 2020-06-30 | $521.00 10-Q · filed 2021-08-23 | $7.68K 10-Q · filed 2021-08-23 | |||||||
| 2020-03-31 | $7.16K 10-Q · filed 2021-06-22 | ||||||||
| 2019-12-31 | $3.64K 10-K/A · filed 2021-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |